XML 36 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Basis of Presentation (Tables)
 9 Months Ended
Sep. 30, 2017
Accounting Policies [Abstract]  
Product Revenue from Sale of Instruments and Consumables and Service Revenue from Custom Assay Development and Sample Processing

The Company had product revenue consisting of revenue from the sale of instruments and consumables for the three and nine months ended September 30, 2017 and 2016, as follows:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Instruments

 

$

199,205

 

 

$

5,846

 

 

$

370,263

 

 

$

88,146

 

Consumables

 

 

426,400

 

 

 

500,219

 

 

 

1,203,663

 

 

 

1,595,236

 

Total product revenue

 

$

625,605

 

 

$

506,065

 

 

$

1,573,926

 

 

$

1,683,382

 

The Company had service revenue consisting of revenue from custom assay development, sample processing and collaborative development services for the three and nine months ended September 30, 2017 and 2016, as follows:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Custom assay development

 

$

73,567

 

 

$

103,719

 

 

$

419,515

 

 

$

103,719

 

Sample processing

 

 

893,618

 

 

 

304,117

 

 

 

2,428,863

 

 

 

1,887,848

 

Collaborative development services

 

 

2,130,694

 

 

 

—

 

 

 

2,433,105

 

 

 

—

 

Total service revenue

 

$

3,097,879

 

 

$

407,836

 

 

$

5,281,483

 

 

$

1,991,567